Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | il y a 1037
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | il y a 780
European Shares Subdued Before Key Inflation Reading

European Shares Subdued Before Key Inflation Reading

European stocks drifted lower on Friday, and the euro consolidated losses ahead of key Eurozone inflation data due later in the day. Earlier in the day, data showed that French consumer price inflation slowed further below the European Central Bank's target in October despite an unexpectedly strong upswing in the economy.
RTTNews | il y a 1h 10min
Asian Shares Mixed; Nikkei Sets New Record As Tech Stocks Surge

Asian Shares Mixed; Nikkei Sets New Record As Tech Stocks Surge

Asian stocks ended mixed on Friday, with Japan's Nikkei hitting a record high on the back of a weaker yen and strong gains in the tech sector while Chinese and Hong Kong markets retreated after a survey showed China's factory activity shrank for a seventh month in October.
RTTNews | il y a 1h 29min
Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan's industrial production rebounded at a stronger-than-expected pace at the end of the third quarter and inflation in Tokyo accelerated further in October, official data revealed Friday. Industrial output advanced 2.2 percent month-on-month, in contrast to the 1.5 percent drop in August, the Ministry of Economy, Trade and Industry said. Output was forecast to grow moderately by 1.5 percent.
RTTNews | il y a 3h 23min
European Shares Seen Tad Lower At Open

European Shares Seen Tad Lower At Open

European markets may open slightly lower on Friday, although tech stocks may rise following strong earnings from e-commerce giant Amazon and iPhone maker Apple.
RTTNews | il y a 4h 32min